Associate Professor
Mayo Clinic Florida
Michael S. Rutenberg, M.D., Ph.D., is a radiation oncologist with a focus on gastrointestinal cancers and bone and soft tissue cancers (sarcomas). His research interests focus on making radiotherapy as effective as possible to treat cancer, while reducing injury to healthy tissue and treatment-associated side effects. The goal of this work is to improve disease control outcomes while maintaining patient quality of life.
Dr. Rutenberg conducts clinical research on multiple diseases, including esophageal cancer, pancreatic cancer, anorectal cancer and sarcomas — particularly chordoma and chondrosarcoma.
Focus areas
Advanced radiotherapy. Dr. Rutenberg studies the use of advanced radiotherapy techniques, including X-ray radiotherapy and particle (proton and carbon ion) therapy. He aims to improve clinical outcomes for diseases such as esophageal cancer, pancreatic cancer and anorectal cancer.
New techniques for treating radioresistant tumors. Dr. Rutenberg researches the use of new radiotherapy techniques to improve treatments for radioresistant tumors such as chordoma and chondrosarcoma.
